Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Novo Begins Study to Find Lowest Effective Dose for Wegovy Pill

Summary by WTVB
LONDON, Aug 19 (Reuters) - Danish drugmaker Novo Nordisk is testing lower doses of its Wegovy pill in a new late-stage study to find the lowest dose that ​still helps patients lose weight, according to a U.S. ‌government database of clinical trials. No...

5 Articles

Lean Right

The Danish pharmacist Novo Nordisk is testing lower doses of her Wegovy tablet in a new advanced phase study to determine the lowest dose that still helps patients lose weight, according to a US government clinical trial database. Novo Nordisk is under pressure after losing space for American rival Eli Lilly in the obesity drug market, which according to analysts is expected to move more than $100 billion a year by 2030. The Wegovy tablet, which…

·Rio de Janeiro, Brazil
Read Full Article
Lean Left

Danish pharmacist already sells slimming medicine in tablets but at higher doses

·Madrid, Spain
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 60% of the sources lean Right
60% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

El Pais broke the news in Madrid, Spain on Wednesday, August 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal